Literature DB >> 15916612

A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates.

Agathe Subtil1, Cédric Delevoye, María-Eugenia Balañá, Laurence Tastevin, Stéphanie Perrinet, Alice Dautry-Varsat.   

Abstract

Chlamydiae are strict intracellular parasites that induce their internalization upon contact with the host cell and grow inside an intracellular compartment called an inclusion. They possess a type III secretion (TTS) apparatus, which allows for the translocation of specific proteins in the host cell cytosol. In particular, chlamydial proteins of the Inc family are secreted to the inclusion membrane by a TTS mechanism; other TTS substrates are mostly unknown. Using a secretion assay based on the recognition of TTS signals in Shigella flexneri, we searched for TTS signals in the proteins of unknown function, conserved between three different chlamydial species, Chlamydia pneumoniae, C. trachomatis and C. caviae. We identified 24 new candidate proteins which did not belong to the Inc family. Four of these proteins were also secreted as full-length proteins by a TTS mechanism in S. flexneri, indicating that their translocation does not require other chlamydial proteins. One of these proteins was detected in the cytosol of infected cells using specific antibodies, directly demonstrating that it is translocated in the host cell during bacterial proliferation. More generally, this work represents the first directed search for TTS effectors not based on genetic information or sequence similarity. It reveals the abundance of proteins secreted in the host cell by chlamydiae.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916612     DOI: 10.1111/j.1365-2958.2005.04647.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  68 in total

1.  Identification of potential type III secretion proteins via heterologous expression of Vibrio parahaemolyticus DNA.

Authors:  Xiaohui Zhou; Seth D Nydam; Jeffrey E Christensen; Michael E Konkel; Lisa Orfe; Patrick Friel; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2012-03-02       Impact factor: 4.792

2.  Structure and protein-protein interaction studies on Chlamydia trachomatis protein CT670 (YscO Homolog).

Authors:  Emily Lorenzini; Alexander Singer; Bhag Singh; Robert Lam; Tatiana Skarina; Nickolay Y Chirgadze; Alexei Savchenko; Radhey S Gupta
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

3.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

5.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

6.  Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements.

Authors:  P Scott Hefty; Richard S Stephens
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

7.  Persistent infection of Chlamydia in reactive arthritis.

Authors:  M Rihl; L Köhler; A Klos; H Zeidler
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

8.  Mechanisms of host cell exit by the intracellular bacterium Chlamydia.

Authors:  Kevin Hybiske; Richard S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

Review 10.  New frontiers in type III secretion biology: the Chlamydia perspective.

Authors:  K E Mueller; G V Plano; K A Fields
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.